BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2164595)

  • 21. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
    Nonkwelo CB; Long WK
    Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
    Horvath GC; Schubach WH
    Biochem Biophys Res Commun; 1993 Feb; 191(1):196-200. PubMed ID: 8383488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.
    Sista ND; Barry C; Sampson K; Pagano J
    Nucleic Acids Res; 1995 May; 23(10):1729-36. PubMed ID: 7784177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.
    Gutsch DE; Holley-Guthrie EA; Zhang Q; Stein B; Blanar MA; Baldwin AS; Kenney SC
    Mol Cell Biol; 1994 Mar; 14(3):1939-48. PubMed ID: 8114725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD.
    Salamun SG; Sitz J; De La Cruz-Herrera CF; Yockteng-Melgar J; Marcon E; Greenblatt J; Fradet-Turcotte A; Frappier L
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
    J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
    J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N; Takada K
    J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
    Ragoczy T; Heston L; Miller G
    J Virol; 1998 Oct; 72(10):7978-84. PubMed ID: 9733836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
    Zalani S; Holley-Guthrie E; Kenney S
    J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
    Gradoville L; Grogan E; Taylor N; Miller G
    Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.
    Yu X; McCarthy PJ; Wang Z; Gorlen DA; Mertz JE
    J Virol; 2012 Aug; 86(15):8086-96. PubMed ID: 22623769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H; Takeshita H; Furukawa M; Seiki M
    J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    Sung NS; Kenney S; Gutsch D; Pagano JS
    J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
    Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC
    J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathways of activation of the Epstein-Barr virus productive cycle.
    Sinclair AJ; Brimmell M; Shanahan F; Farrell PJ
    J Virol; 1991 May; 65(5):2237-44. PubMed ID: 1850009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of transactivator and nuclear localization domains in the Epstein-Barr virus DNA polymerase accessory protein, BMRF1.
    Zhang Q; Holley-Guthrie E; Dorsky D; Kenney S
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():69-74. PubMed ID: 9934686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.